Search for: "Sanofi Aventis US Inc" Results 1 - 20 of 160
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Feb 2023, 12:00 pm by Bernard Bell
In 1996, HHS issued guidance limiting covered entities to using one contract pharmacy. [read post]
20 Aug 2010, 4:47 am by Varun Chhonkar
Judge Gregory Sleet of the US District Court for the District of Delaware lately decided in favor of Sanofi-Aventis in Uroxatral patent lawsuit and ruled that Sanofi’s US Patent Number 4,661,491 is valid and infringed by generic alfuzosin versions from Aurobindo Pharma and Torrent Pharma Inc. [read post]
9 Jan 2011, 9:09 pm by Patent Docs
USA 1:11-cv-00018; filed January 6, 2011 in the District Court of Delaware • Plaintiffs: Aventis Pharma S.A.; Sanofi-Aventis U.S. [read post]
13 Sep 2008, 4:35 am
Recent news reports have allowed us to add four more companies to the list: • Sanofi-Aventis' U.S. subsidiary spent more than $1.2 million on second quarter lobbying (see Forbes.com report). [read post]
27 Aug 2019, 9:59 pm by Patent Docs
The case arose in ANDA litigation involving Sanofi's Jevtana® (cabazitaxel), having the structure: where the methoxy... [read post]
8 Dec 2010, 6:07 pm by Larry Jones
  The medications include Abbott Laboratories Inc's Lupron, AstraZeneca's Zoladex and Sanofi-Aventis SA's Eligard.According to the FDA, the drugs, known as gonadotropin-releasing hormone (GnRH) agonists, are used to suppress the production of testosterone, a hormone that helps fuel prostate cancer growth. [read post]
2 Sep 2008, 12:39 am
Sanofi-Aventis et al. v. [read post]
14 Mar 2014, 1:02 pm
The individual filed suit in Cook County Circuit Court against Bristol-Myers Squibb Co., Sanofi-Aventis US LLC, Sanofi-Aventis US Inc., and Sanofi-Synthelabo Inc. in a claim of strict product liability, manufacturing defect, negligence, and failure to warn. [read post]
5 Sep 2017, 7:45 am by Ben Vernia
On August 17, the Department of Justice announced that the pharmaceutical company Mylan and its subsidiary had agreed to pay $465 million to the federal and state governments to settle allegations, originally brought by the company’s competitor, Sanofi-Aventis US LLC, that it had defrauded the Medicaid program by falsely declaring its epinephrine syringe, the Epi-Pen, to be a generic device. [read post]
22 Apr 2014, 7:41 am
United Parcel Serv., Inc., 665 F.3d 68, 73 (3d Cir. 2012).Sanofi-Aventis Deutschland GMBH at *12.Jury InstructionsYou may make an adverse inference in this case against Glenmark. [read post]
21 Dec 2009, 7:51 am
This morning, the big news in deal-land is that Sanofi-Aventis (SNY) is buying Chattem Inc. [read post]
26 Jan 2007, 6:09 am
In August 2006, generic drug maker Apotex Inc. began selling a cheaper version of Plavix, a blood thinner Bristol-Myers co-markets with Sanofi-Aventis SA, after an agreement to settle a patent dispute fell apart. [read post]